Literature DB >> 33262058

Disparities in availability of services and prediction of the readiness of primary healthcare to manage diabetes in Tanzania.

Deogratius Bintabara1, Festo K Shayo2.   

Abstract

BACKGROUND: The burdens of Non-communicable Diseases have overstretched health systems in developing countries. The study explores disparities in the availability of services and predicts the readiness of primary healthcare facilities to manage diabetes in Tanzania.
METHODS: The study analyzed data from the 2014-2015 Tanzania Service Provision Assessment Survey. A total of 1142 primary healthcare facilities were included in this analysis. The Negative binomial regression models were fitted to predict each of selected independent variable that is associated with the readiness of primary healthcare to manage diabetes.
RESULTS: The overall availability of services was significantly different across the type of facility and managing authority. In an adjusted model, the following were the predictors for a significant increase in readiness to manage diabetes: health center [β = 0.470], private facilities [β = 0.252], the performance of management meetings [β = 0.446], having source of fund other than government [β = 0.193,], and presence of medical doctors [β = 0.677].
CONCLUSION: The robust primary care systems to manage diabetes could be achieved by improving the readiness of primary healthcare facilities through optimizing the availability of diagnostic tools, basic medicines, medical doctors, and early release of a government fund to publicly-owned facilities.
Copyright © 2020 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes; Facility readiness; Primary healthcare; Tanzania

Year:  2020        PMID: 33262058     DOI: 10.1016/j.pcd.2020.11.007

Source DB:  PubMed          Journal:  Prim Care Diabetes        ISSN: 1878-0210            Impact factor:   2.459


  1 in total

1.  Integrating HIV, diabetes and hypertension services in Africa: study protocol for a cluster randomised trial in Tanzania and Uganda.

Authors:  Sayoki Godfrey Mfinanga; Moffat J Nyirenda; Gerald Mutungi; Janneth Mghamba; Sarah Maongezi; Joshua Musinguzi; Joseph Okebe; Sokoine Kivuyo; Josephine Birungi; Erik van Widenfelt; Marie-Claire Van Hout; Max Bachmann; Anupam Garrib; Dominic Bukenya; Walter Cullen; Jeffrey V Lazarus; Louis Wihelmus Niessen; Anne Katahoire; Elizabeth Henry Shayo; Ivan Namakoola; Kaushik Ramaiya; Duolao Wang; L E Cuevas; Bernard M Etukoit; Janet Lutale; Shimwela Meshack; Kenneth Mugisha; Geoff Gill; Nelson Sewankambo; Peter G Smith; Shabbar Jaffar
Journal:  BMJ Open       Date:  2021-10-13       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.